Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Sexually transmitted infections tests and treatment news


From To
PrEP services could enhance STI control, says World Health Organization

The roll-out of pre-exposure prophylaxis (PrEP) provides an opportunity to bring down the incidence of sexually transmitted infections (STIs), provided that PrEP and STI programmes are better

22 July 2019
Roger Pebody
FDA Approves First Throat and Rectal Tests for Detecting Chlamydia and Gonorrhea

The U.S. Food and Drug Administration (FDA) announced on May 23 that it had cleared the Aptima Combo 2 Assay and Xpert CT/NG to detect chlamydia and gonorrhea by using throat and rectum samples, potentially making it easier for physicians and public health programs to diagnose and treat sexually transmitted infections (STIs) that are often undertreated for lack of testing in those areas.

02 June 2019
The Body Pro
Drug combination could be effective for treatment-resistant gonorrhea

Scientists comparing treatments for gonorrhea have identified a drug combination that could be an effective back-up for patients not responding to current therapy. The research team, from University Hospitals Birmingham, found that a treatment of the antibiotic gentamicin with azithromycin worked almost as well as the currently used ceftriaxone for genital gonorrhea.

07 May 2019
Eurekalert Inf Dis
Pipeline for Gonorrhea, Chlamydia, and Syphilis

A new report on the sexually transmitted infection (STI) treatment and prevention research “pipeline” points to serious gaps in the development of new tools to address a growing epidemic in the U.S. The report, released today by Treatment Action Group (TAG), provides an assessment of the current research pipeline and calls for a major new investment in STI research.

20 March 2019
Sex clinics show how competition can improve England’s NHS

Patients can walk into clinics without a referral, so providers have to compete for their business.

15 March 2019
The Economist (requires free registration)
Illegal STI drugs being sold online

Unlicensed antibiotics are being advertised on social media as treatment for sexually transmitted infections and sold at the wrong dose.

04 March 2019
BBC Health
Gonorrhoea: drug resistance compromises recommended treatment in Europe

In 2017, 27 EU/EEA countries collected and tested 3 248 gonococcal isolates which revealed that cefixime and azithromycin resistance (1.9% and 7.5% respectively) remained unchanged compared to 2016 (2.1% and 7.5%). However, the number of countries reporting resistant isolates for each antimicrobial increased. For the second year in a row, no isolates with resistance to ceftriaxone were detected in contrast to one in 2015, five in 2014 and seven in 2013.

28 February 2019
UK Gonorrhea Guideline Guards Against Antibiotic Resistance

A new guideline on the management of gonorrhea has been issued by the British Association for Sexual Health and HIV. The 2019 guideline introduced changes made to the 2011 guideline including: removing the recommendation for dual therapy with azithromycin, increasing the dose of ceftriaxone, recommending the use of ciprofloxacin in certain cases, and adding extra-genital testing in cases of known or suspected antimicrobial resistance.

30 January 2019
MD Magazine
This Is What It’s Like To Lose Your Local Sexual Health Clinic Under Austerity

In a new series, HuffPost UK is examining how shrinking local budgets are affecting people’s daily lives. These are stories of what it’s like to lose, in a society that is quietly changing.

23 January 2019
Huffington Post
Testing times: four emerging STIs that you can’t afford to ignore

Although gonorrhoea, chlamydia and syphilis grab most of the headlines, public health officials are warily watching the emergence of other bacterial sexually transmitted infections.

06 December 2018
← First12345...6Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.